Table 2 Clinical features of all participants in the normal and increased IMT groups

Age (years)^*

64.56 ± 11.33

62.93 ± 11.93

Male/Female sex

91 (62.33)/55 (37.67)

125 (56.31)/97 (43.69)

BMI (kg/m²)^*

23.48 ± 2.76

23.59 ± 2.84

IMT (mm)^*

0.98 ± 0.05

1.17 ± 0.09

Carotid plaques

119 (81.51)

184 (82.29)

Hypertension

101 (69.18)

165 (74.34)

Diabetes

41 (28.08)

56 (25.23)

Smoker

42 (28.77)

67 (30.18)

Drinker

34 (23.29)

61 (27.48)

Glucose (mmol/L)^*

6.78 ± 2.62

6.67 ± 2.01

TC (mmol/L)^*

3.76 ± 0.88

3.90 ± 0.93

TG (mmol/L)^*

1.51 ± 1.44

1.36 ± 0.76

LDL-C (mmol/L)^*

2.16 ± 0.65

2.20 ± 0.65

sdLDL-C (mg/dl)^*

21.97 ± 20.29

26.07 ± 20.37

HDL-C (mg/dl)^*

41.76 ± 12.02

42.01 ± 13.15

Non-HDL-C (mmol/L)^*

24.52 ± 27.36

24.19 ± 13.86

Statin therapy

6 (4.11%)

9 (4.05%)